{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:50:14Z","timestamp":1769457014802,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.rec.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T14:31:05Z","timestamp":1477665065000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain"],"prefix":"10.1016","volume":"70","author":[{"given":"Mar\u00eda","family":"Sabater-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Saura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Garc\u00eda-Molina S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefa","family":"Gonz\u00e1lez-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"Olmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Oliva-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Barriales-Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domigo","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan R.","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2016.06.020_bib0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjmed.2003.10.012","article-title":"Hypertrophic cardiomyopathy: an important global disease","volume":"116","author":"Maron","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.rec.2016.06.020_bib0210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2016.06.020_bib0215","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.rec.2016.06.020_bib0220","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/bmm.13.79","article-title":"Genetic biomarkers in hypertrophic cardiomyopathy","volume":"7","author":"Coats","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.rec.2016.06.020_bib0230","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2016.06.020_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1399-0004.2003.00151.x","article-title":"Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy","volume":"64","author":"Erdmann","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.rec.2016.06.020_bib0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.res.0000435859.24609.b3","article-title":"Organization and sequence of human cardiac myosin-binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy","volume":"80","author":"Carrier","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.rec.2016.06.020_bib0245","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(01)01387-0","article-title":"Spectrum of clinical phenotypes and gene variants in cardiac myosin- binding protein C mutations with hypertrophic cardiomyopathy","volume":"38","author":"Erdmann","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0250","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","article-title":"Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3","volume":"96","author":"Oliva-Sandoval","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.rec.2016.06.020_bib0255","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/CIRCULATIONAHA.114.011207","article-title":"Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation","volume":"130","author":"Adalsteinsdottir","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2016.06.020_bib0260","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/hrt.77.2.130","article-title":"Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families","volume":"77","author":"McKenna","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.rec.2016.06.020_bib0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-2828(03)00050-6","article-title":"Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy","volume":"35","author":"Waldm\u00fcller","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0275","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jacc.2005.05.087","article-title":"Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese","volume":"46","author":"Kubo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2350-13-105","article-title":"A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death","volume":"13","author":"Teirlinck","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.rec.2016.06.020_bib0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853890.2012.671534","article-title":"Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population","volume":"45","author":"J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.rec.2016.06.020_bib0290","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/eurjhf\/hft013","article-title":"Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years\u2019 experience","volume":"15","author":"Van Spaendonck-Zwarts","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.rec.2016.06.020_bib0295","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.rec.2016.06.020_bib0300","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000346146","article-title":"Progress in the molecular genetics of hypertrophic cardiomyopathy: a mini-review","volume":"59","author":"Tian","year":"2013","journal-title":"Gerontology"},{"key":"10.1016\/j.rec.2016.06.020_bib0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jmedgenet-2012-101270","article-title":"Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing","volume":"50","author":"Lopes","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.rec.2016.06.020_bib0310","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rec.2016.06.020_bib0315","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2016.06.020_bib0320","doi-asserted-by":"crossref","first-page":"e001002","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high\u2013risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rec.2016.06.020_bib0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacc.2004.01.054","article-title":"Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy","volume":"44","author":"Thaman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.rec.2016.06.020_bib0335","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0195-668X(03)00466-4","article-title":"The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands","volume":"24","author":"Alders","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rec.2016.06.020_bib0340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(01)01387-0","article-title":"Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy","volume":"38","author":"Erdmann","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0345","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0735-1097(01)01389-4","article-title":"On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture","volume":"38","author":"Marian","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0350","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2004.07.045","article-title":"Myosin-binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy","volume":"44","author":"Van Driest","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0355","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.ejhg.5201649","article-title":"Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease","volume":"14","author":"Khajavi","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.rec.2016.06.020_bib0360","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"Holbrook","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.rec.2016.06.020_bib0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardiores.2005.01.004","article-title":"Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants","volume":"66","author":"Sarikas","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.rec.2016.06.020_bib0370","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","author":"Vignier","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.rec.2016.06.020_bib0375","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1172\/JCI3880","article-title":"A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy","volume":"102","author":"Yang","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rec.2016.06.020_bib0380","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rec.2016.06.020_bib0385","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2016.06.020_bib0390","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.rec.2016.06.020_bib0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1157\/13097921","article-title":"Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy","volume":"60","author":"Dumont","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rec.2016.06.020_bib0400","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716302754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716302754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T04:06:35Z","timestamp":1568520395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585716302754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1885585716302754"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2016.06.020","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2016.06.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}